| Arquivos de Gastroenterologia | |
| Chloroquine for the maintenance of remission of autoimmune hepatitis: results of a pilot study | |
| Marcos Mucenic2  Evandro Sobroza De Mello1  Eduardo Luiz R. Cançado2  | |
| [1] ,University of São Paulo School of Medicine Department of Gastroenterology São Paulo SP ,Brazil | |
| 关键词: Chloroquine; Hepatitis; Antigen presentation; HLA antigens; Cloroquina; Hepatite auto-imune; Apresentação do antígeno; Antígenos HLA; | |
| DOI : 10.1590/S0004-28032005000400011 | |
| 来源: SciELO | |
PDF
|
|
【 摘 要 】
BACKGROUND: Due to the risks related to long-term treatment with prednisone and azathioprine, most clinicians try to withdraw these drugs when patients with autoimmune hepatitis are in remission. However, there is a high probability of relapse, and most patients end up receiving maintenance treatment. AIM: To evaluate the safety and efficacy of maintenance treatment with chloroquine in the prevention of autoimmune hepatitis relapses. METHODS: Classical treatment was stopped after achievement of biochemical and histological remission of autoimmune hepatitis. Chloroquine diphosphate, 250 mg daily, was given for at least 12 months or until the occurrence of relapses defined by levels of aminotransferases at least twice the upper normal values. RESULTS: Fourteen patients were consecutively treated and compared with 18 historical controls. There was a 6.49 (1.38-30.30) greater chance of relapse in the historical controls when compared with patients treated with chloroquine (72.2% x 23.5%; 0.031). CONCLUSIONS: The group treated with chloroquine had a lower frequency of relapses. Chloroquine was safe in patients with autoimmune hepatitis and hepatic cirrhosis without decompensation, on 250 mg daily up to 2 years. These preliminary results provide a basis for upcoming controlled studies comparing chloroquine with placebo or for maintenance treatment with prednisone and/or azathioprine for the prevention of autoimmune hepatitis relapses.
【 授权许可】
CC BY-NC
All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202005130004112ZK.pdf | 250KB |
PDF